News

Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting ...
By Fernanda Wenzel In 2023, Brazil’s Federal Police spotted an unusual movement in the small airport of Santarém, in Pará ...
The first patient was dosed in the Phase 1 ZOLAR 7 trial of TLX300-CDx ( 89 Zr-olaratumab), which aims to validate the use of olaratumab, an antibody exclusively licensed from Eli Lilly and Company ...
By John Alam of Urus Advisory Historically, it is the ultimate crossroads between Europe, the Middle East, South Asia and ...